Hap Trading, LLC Citius Pharmaceuticals, Inc. Call Options Transaction History

Hap Trading, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$0.14 - $1.33 $2,884 - $27,398	20,600 Added 158.46%	33,600 $4,000
Q2 2022 Aug 12, 2022	SELL	$0.88 - $1.87 $18,304 - $38,896	-20,800 Reduced 61.54%	13,000 $0
Q1 2022 May 12, 2022	SELL	$1.38 - $1.89 $183,540 - $251,370	-133,000 Reduced 79.74%	33,800 $3,000
Q4 2021 Feb 14, 2022	BUY	$1.51 - $2.2 $175,311 - $255,420	116,100 Added 228.99%	166,800 $17,000
Q3 2021 Nov 10, 2021	BUY	$1.74 - $2.6 $88,218 - $131,820	50,700 New	50,700 $14,000

26.7M

Ticker CTXR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,130,000
Market Cap $140M
Description
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.